In critical care settings, healthcare professionals frequently face life-and-death situations. However, in these highly monitored environments, where advanced surveillance equipment and expert clinical care are in place, are so-called “sudden deaths” truly unpredictable? When medical disputes arise and “sudden death” is cited as the cause, we must question whether these deaths were truly unforeseeable, or if they were the culmination of systemic issues that could have been identified and addressed in advance.
Genuine sudden deaths can occur without warning. However, in many clinical scenarios, “sudden death” is not truly abrupt, but rather the result of prolonged deterioration evident hours or even days before the fatal event. Did the patient exhibit early signs of organ failure? Were there indications of sepsis? Did monitoring data signal impending danger?
One of the core functions of critical care units is to provide continuous monitoring and timely intervention. Electrocardiograms, oxygen saturation monitoring, arterial blood pressure measurements and sophisticated biochemical indicators allow medical teams to foresee risks and take preventive measures.
Yet, when a patient dies suddenly, the explanation often defaults to “disease progression” or “uncontrollable factors.” This raises serious concerns: Were the warning signs ignored? Did the medical team fail to utilize available monitoring tools effectively?
If monitoring technology has become highly advanced, why do sudden deaths continue to occur so frequently? The root of the problem lies not in a lack of tools, but in the culture of medicine and systemic management flaws that prevent these tools from being effectively utilized.
In many hospitals, monitoring systems are capable of capturing a wealth of physiological data in real time. Yet, in practice, these data are often treated more as decoration than resource. Medical teams tend to operate reactively — waiting for clear signs of deterioration rather than anticipating and preventing risks. As a result, patients might reach an irreversible stage before any meaningful intervention takes place.
This problem is compounded by the pervasive hold of defensive medicine. In environments where medical disputes are common, hospital administrators might implicitly encourage staff to be cautious not in treating patients, but in avoiding blame. This fosters a culture where early warning signs are downplayed and high-risk conditions are managed conservatively — or not at all.
When the fear of being wrong outweighs the urgency of being right, the medical system shifts its focus from preventing harm to minimizing liability. In such a culture, preventable deaths can too easily be dismissed as “sudden.”
Another critical issue is the lack of transparency. Internal hospital reviews are rarely open to outside scrutiny, and death certificates often offer vague conclusions such as “cardiac arrest” or “multiple organ failure” without deeper investigation. Key details are left unmentioned. Without such details, patterns are missed, lessons are lost and similar tragedies are destined to repeat.
Sudden deaths should be the exception, not the norm. Tackling this issue demands a fundamental shift in mindset. One key step is enhancing early warning mechanisms within critical care. Instead of relying solely on human judgement to identify obvious signs of deterioration, hospitals should adopt proactive strategies that leverage technology — such as artificial intelligence monitoring systems capable of detecting subtle, but meaningful changes in a patient’s condition. These tools could alert staff before a crisis unfolds, allowing for timely intervention that could save lives.
Equally important is the need to transform the prevailing medical culture. Doctors and nurses must be able to act decisively and diagnose early, without the looming fear of blame. Institutions should prioritize a supportive framework that encourages active intervention and shared responsibility, moving away from defensive medicine. Only then could patient care become proactive rather than reactive.
Transparency plays a crucial role. All “sudden deaths” should undergo mandatory, independent review — not to assign fault, but to uncover hidden systemic failures and foster continuous learning. By shining a light on these incidents, hospitals could begin to address the root causes.
The essence of critical care is not in passively observing decline, but in acting with precision and urgency. Patients should not be allowed to slip away under watchful eyes. When we look closely, what often emerges is not the unpredictability of nature, but the failure of the system — delayed clinical decisions, neglected data and a medical culture that tolerates inaction.
To break this cycle, Taiwan needs sweeping reforms — accountability, a culture that rewards vigilance and technology that drives timely action. Only then can we return to medicine’s core mission: to save lives.
Chu Jou-juo is a professor in the Department of Labor Relations at National Chung Cheng University.
The conflict in the Middle East has been disrupting financial markets, raising concerns about rising inflationary pressures and global economic growth. One market that some investors are particularly worried about has not been heavily covered in the news: the private credit market. Even before the joint US-Israeli attacks on Iran on Feb. 28, global capital markets had faced growing structural pressure — the deteriorating funding conditions in the private credit market. The private credit market is where companies borrow funds directly from nonbank financial institutions such as asset management companies, insurance companies and private lending platforms. Its popularity has risen since
The Donald Trump administration’s approach to China broadly, and to cross-Strait relations in particular, remains a conundrum. The 2025 US National Security Strategy prioritized the defense of Taiwan in a way that surprised some observers of the Trump administration: “Deterring a conflict over Taiwan, ideally by preserving military overmatch, is a priority.” Two months later, Taiwan went entirely unmentioned in the US National Defense Strategy, as did military overmatch vis-a-vis China, giving renewed cause for concern. How to interpret these varying statements remains an open question. In both documents, the Indo-Pacific is listed as a second priority behind homeland defense and
Every analyst watching Iran’s succession crisis is asking who would replace supreme leader Ayatollah Ali Khamenei. Yet, the real question is whether China has learned enough from the Persian Gulf to survive a war over Taiwan. Beijing purchases roughly 90 percent of Iran’s exported crude — some 1.61 million barrels per day last year — and holds a US$400 billion, 25-year cooperation agreement binding it to Tehran’s stability. However, this is not simply the story of a patron protecting an investment. China has spent years engineering a sanctions-evasion architecture that was never really about Iran — it was about Taiwan. The
In an op-ed published in Foreign Affairs on Tuesday, Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文) said that Taiwan should not have to choose between aligning with Beijing or Washington, and advocated for cooperation with Beijing under the so-called “1992 consensus” as a form of “strategic ambiguity.” However, Cheng has either misunderstood the geopolitical reality and chosen appeasement, or is trying to fool an international audience with her doublespeak; nonetheless, it risks sending the wrong message to Taiwan’s democratic allies and partners. Cheng stressed that “Taiwan does not have to choose,” as while Beijing and Washington compete, Taiwan is strongest when
RSS